Kara Chew
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses (NCT06810934) | Kara Chew | 2025-10-21 |
Track Kara Chew automatically
Every clearance here is in the API, with alerts when new ones post.